Performance of three clinical scores for steatosis and steatohepatitis and their interaction with metabolic syndrome in obese individuals
NLFS, HSI, and FLI show limited accuracy in obese individuals. Adjusting thresholds improves performance. Diagnostic utility remains consistent regardless of MetS, supporting their use across the MASLD spectrum.
Authors
- Tiago Lemos Cerqueira (ORCID: https://orcid.org/0000-0002-8651-4728)
- Daniel Cecconi Agostini
- Jonathan Soldera (ORCID: https://orcid.org/0000-0001-6055-4783)
- Ana Maria Graciolli
- Floriano Riva
- Cassiano Scholze (ORCID: https://orcid.org/0000-0002-3403-5506)
- Augusto Cardoso Sgarioni
- Aline Caldart Tregnago
- Henrique Prataviera Giovanardi
- Stéfano Mateus Schio Kuiava
- Carlos Henrique Dal Bem Fistarol
- Laura Kalil Nader Lazzaretti
- Arturo Tamayo
- Bruno Dellamea
- Emanuelle Mendonça Pandolfo
- Ben Min-Woo Illigens
- Bárbara Brambilla
- Vitória Maria Kriger
Institutions
- Harvard University (US)
- Logan Hospital (AU)
- Universidade de Caxias do Sul (BR)
- Lear (Spain) (ES)
- Dresden International University (DE)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.4254/wjh.v18.i2.111962
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00